Columnist Caroline Gainer experiences relentless fatigue, chills, and sweating, possibly from COPD and/or chronic ...

Note: This column describes the author’s own experiences with guaifenesin. Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. We always ...

Although there is no cure for COPD yet, there are several approved treatments that can help manage the disease and ease symptoms. Learn more about some of the specific therapies used to treat this ...

Note: This is the second article in a three-part series written in collaboration with respiratory therapist Mark W. Mangus Sr., RRT, RPFT, FAARC, and oxygen expert Ryan Diesem. The first part can be ...

People with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) may experience fewer acute disease exacerbations if they regularly use noninvasive ventilation at night, a ...

DirectRx, a specialty pharmacy for people with chronic health disorders, is now part of the exclusive U.S. pharmacy network distributing Ohtuvayre (ensifentrine), a newly approved therapy for chronic ...

While the name of this column is “Life Tethered to a Concentrator,” so far, I haven’t yet discussed my journey with long-term supplemental oxygen. Today, I’d like to take you along on that journey.

The U.S. Food and Drug Administration (FDA) has approved Abrysvo, a vaccine that protects against lung infections caused by the respiratory syncytial virus — commonly known as RSV — for adults as ...

Yupelri (revefenacin) is not superior to Spiriva (tiotropium) at improving lung function in adults with severe chronic obstructive pulmonary disease (COPD), according to data from a Phase 4 clinical ...

Note: This is the first part of a three-part series written in collaboration with respiratory therapist Mark W. Mangus Sr., RRT, RPFT, FAARC, and oxygen expert Ryan Diesem. One of the more hotly ...

It’s not uncommon for those of us with chronic obstructive pulmonary disease (COPD) to suffer from cachexia, or wasting disease. A 2019 study found that people with cachexia or pre-cachexia had a ...

Verona Pharma has launched two Phase 3 trials to assess the safety and effectiveness of ensifentrine, its investigational inhalation treatment for chronic obstructive pulmonary disease (COPD). The ...